Skip to content
MedsAcross

Medicine

Bupropion 100 mg extended-release tablet

Bupropion · Oral
Available on requestPrescription onlyUS FDAGeneric name

Bupropion 100 mg extended-release tablet is a generic prescription medicine for oral use, made by 24 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F). Protect from light and moisture.

Key facts

Active ingredient (INN)
Bupropion
Brand
Sold under the generic name
Strength
100 mg
Dosage form
Extended-release tablet
Route
Oral
Packs
100 tablets, 500 tablets, 60 tablets and 92 more
Manufacturers
Dr. Reddy's LaboratoriesIndiaCiplaIndiaCamber PharmaceuticalsIndiaGranules IndiaIndiaMacleods PharmaceuticalsIndiaAurobindo PharmaIndiaEpic PharmaScieGen PharmaceuticalsActavis PharmaDriectRx24 labelers on the register
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F). Protect from light and moisture.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N06AX12 Bupropion
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
24 March 2009
Identifiers
RxCUI 993503, 993518, 993536 +2DailyMed set ID cec41945-8d64-4793-8784-4c2b8ec37b0f, 38f52cec-9534-dab8-e063-6294a90a0704, 9d0608a1-0cc8-491a-ad91-238e0ea009fe +31NDC 0591-3540, 67046-1572, 72789-158 +31Application ANDA079095, ANDA216800, ANDA205794 +9

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 24 labelers. The register lists 95 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
100 tablet, film coated, extended release in 1 bottle, plastic43598-536-01Dr. Reddy's LaboratoriesIndia1 August 2016
500 tablet, film coated, extended release in 1 bottle, plastic43598-536-05Dr. Reddy's LaboratoriesIndia1 August 2016
60 tablet, film coated, extended release in 1 bottle, plastic43598-536-60Dr. Reddy's LaboratoriesIndia1 August 2016
100 tablet, film coated, extended release in 1 bottle, plastic43598-751-01Dr. Reddy's LaboratoriesIndia15 May 2018
500 tablet, film coated, extended release in 1 bottle, plastic43598-751-05Dr. Reddy's LaboratoriesIndia15 May 2018
60 tablet, film coated, extended release in 1 bottle, plastic43598-751-60Dr. Reddy's LaboratoriesIndia15 May 2018
100 tablet, film coated, extended release in 1 bottle59651-846-01Aurobindo PharmaIndia3 June 2025
500 tablet, film coated, extended release in 1 bottle59651-846-05Aurobindo PharmaIndia3 June 2025
100 tablet, extended release in 1 bottle31722-066-01Camber PharmaceuticalsIndia31 May 2023
500 tablet, extended release in 1 bottle31722-066-05Camber PharmaceuticalsIndia31 May 2023
60 tablet, extended release in 1 bottle31722-066-60Camber PharmaceuticalsIndia31 May 2023
30 tablet, extended release in 1 bottle69097-877-02CiplaIndia25 July 2016
60 tablet, extended release in 1 bottle69097-877-03CiplaIndia25 July 2016
100 tablet, extended release in 1 bottle69097-877-07CiplaIndia25 July 2016
500 tablet, extended release in 1 bottle69097-877-12CiplaIndia25 July 2016
30 tablet, film coated, extended release in 1 bottle70010-125-03Granules IndiaIndia31 March 2025
500 tablet, film coated, extended release in 1 bottle70010-125-05Granules IndiaIndia31 March 2025
60 tablet, film coated, extended release in 1 bottle70010-125-06Granules IndiaIndia31 March 2025
60 tablet, extended release in 1 bottle33342-526-09Macleods PharmaceuticalsIndia23 June 2026
100 tablet, extended release in 1 bottle33342-526-11Macleods PharmaceuticalsIndia23 June 2026
500 tablet, extended release in 1 bottle33342-526-15Macleods PharmaceuticalsIndia23 June 2026
100 tablet, extended release in 1 bottle42806-410-01Epic Pharma15 December 2021
500 tablet, extended release in 1 bottle42806-410-05Epic Pharma15 December 2021
60 tablet, extended release in 1 bottle42806-410-60Epic Pharma15 December 2021
100 tablet, extended release in 1 bottle42806-424-01Epic Pharma18 September 2023
500 tablet, extended release in 1 bottle42806-424-05Epic Pharma18 September 2023
60 tablet, extended release in 1 bottle42806-424-60Epic Pharma18 September 2023
100 tablet, extended release in 1 bottle42806-441-01Epic Pharma30 September 2026
500 tablet, extended release in 1 bottle42806-441-05Epic Pharma30 September 2026
60 tablet, extended release in 1 bottle42806-441-60Epic Pharma30 September 2026
500 tablet, film coated, extended release in 1 bottle, plastic0591-3540-05Actavis Pharma2 July 2009
60 tablet, film coated, extended release in 1 bottle, plastic0591-3540-60Actavis Pharma2 July 2009
30 tablet, extended release in 1 bottle72189-676-30DriectRx30 April 2026
60 tablet, extended release in 1 bottle72189-676-60DriectRx30 April 2026
500 tablet, film coated, extended release in 1 bottle, plastic77771-174-05Radha Pharmaceuticals15 April 2021
60 tablet, film coated, extended release in 1 bottle, plastic77771-174-60Radha Pharmaceuticals15 April 2021
100 tablet, film coated, extended release in 1 bottle, plastic50228-174-01ScieGen Pharmaceuticals20 April 2018
500 tablet, film coated, extended release in 1 bottle, plastic50228-174-05ScieGen Pharmaceuticals20 April 2018
1000 tablet, film coated, extended release in 1 bottle, plastic50228-174-10ScieGen Pharmaceuticals20 April 2018
30 tablet, film coated, extended release in 1 bottle, plastic50228-174-30ScieGen Pharmaceuticals20 April 2018

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 30 December 1985Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Bupropion

Clinical summary

Bupropion is an aminoketone indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM). It is available as extended-release tablets and tablets for oral use. MedsAcross supplies Bupropion for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Bupropion

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Bupropion 100 mg extended-release tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.